Investments and investor services
FTSE 100 finishes in the red as BoE keeps rates on hold
FTSE 100 closed down over 48 points at 7,448., while FTSE 250 shed over 55 to 20,006
Company
Faron Pharmaceuticals Limited
LON:FARN
Faron Pharmaceuticals is a global, clinical-stage biopharmaceutical company, focused on creating innovative cancer treatments that leverage the patient’s own immune system. The company’s lead asset bexmarilimab is currently being investigated in Phase I/II clinical trial as a potential therapy for patients with hematological cancers in combination with other standard treatments.
418 stories · page 18 of 21
Archive
Proactive news snapshot: Hurricane Energy, Cadence Minerals, Flying Brands …
A glance at some of the day's highlights from the Proactive Investors newswire
Vela Technologies flying high after investee company bags deal with American Airlines
Vela Technologies PLC flying high after investee company bags deal with American Airlines
Faron Pharmaceuticals completes recruitment for phase III trials of its ARDS treatment
300 patients have now been recruited across Europe for the trial which is looking at whether Traumakine can reduce all-cause mortality in acute respiratory distress syndrome sufferers
Investments and investor services
FTSE 100 closes higher as miners gain and sterling slides
The FTSE 100 closed the day higher, as the weak pound helped, while other European indices lagged
Archive
Proactive news snapshot: Rose Petroleum, LEKOIL, Diversified Gas & Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Broker downgrades send Royal Mail and Babcock International lower
Some of the biggest risers and fallers in London on Friday.
Faron Pharmaceuticals hires chief commercial officer ahead of drug launch
Dr Juhana Heinonen will join the business in January from AstraZeneca
Investments and investor services
FTSE 100 slides as Trump impeachment fears resurface
The Teflon president faced another test of his lucky rabbit's foot's effectiveness
Archive
Proactive news snapshot: Rose Petroleum, Ortac Resources, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
SSE rallies despite HSBC trimming its price target
SSE may have rallied, but Centrica remained down in the dumps, after HSBC trimmed its price target for the British Gas owner to 190p from 202p.
Faron Pharmaceuticals' £10mln fundraiser will accelerate progress
Shares are being issued at 800p each, which is a modest 2% discount to Wednesday’s closing price
FTSE 100 closes firmly in positive territory as sterling slides
The FTSE 100 rose to within a couple of points of 7,500 after US markets opened higher
Archive
Proactive news snapshot: Hurricane Energy, AFC Energy, Canadian Overseas Petroleum …
A glance at some of the day's highlights from the Proactive Investors newswire
Greencore Group dives following product recall in the US
The US Food and Drug Administration's sampling found some Listeria monocytogenes in Greencore's sandwiches
Faron Pharmaceuticals' lead drug gets significant vote of confidence from UK regulator
The Medicines and Healthcare Products Regulatory Agency has given Faron drug,Traumakine, a Promising Innovative Medicines designation
FTSE 100 closes firmly higher as weak pound gives it a boost
FTSE 100 closed over 66 points higher at 7,438 with budget carrier easyJet the top flyer
Archive
Proactive news snapshot: Synairgen, Silence Therapeutics, LoopUp Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Cyber security firm Shearwater soars as chairman increases holding
Sports Direct, Barratt Developments, Ryanair and EasyJet were among Wednesday's early market movers.